Genvoya Tablet
Pricing Report NDC 61958-1901-1

Current NADAC: $143.35320 per EA · Effective Sep 23, 2026 · Est. package price $4,300.60 (30 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Genvoya (NDC 61958-1901-1) is $143.35320 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Gilead Sciences, Inc., this medication is distributed in a 30 TABLET in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$143.35320
Per EA

Effective Date
Sep 23, 2026
Billable Units
30 EA
Estimated Package Price
$4,300.60
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2016, the NADAC wholesale price for (NDC ) has moved within a range of $82.73509 to $143.35320 per EA. Over this 10 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$82.7351 - $143.3532
Market Volatility
73.27% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $143.35320 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $143.32827 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $143.31288 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $143.34972 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $143.34164 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 01, 2026 $143.35012 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 01, 2026 $143.35012 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 01, 2026 $143.35012 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $136.65407 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $136.64954 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $136.65470 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $136.65214 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026